Diligence memo · auto-generated · as of July 2, 2026
BioMEMS Diagnostics, Inc.
BioMEMS Diagnostics, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioMEMS Diagnostics, Inc. operates in Medical Devices, based in COMMERCE.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioMEMS Diagnostics, Inc. has raised $3.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2023-01-17.
Most recent recorded round closed around 2023-01-17.
Valuation (modeled)modeled
Provath models BioMEMS Diagnostics, Inc. at approximately $27M (range $2.4M–$107M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 3.43× the median modeled value of Seed Medical Devices companies in 2022–2024 (15 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 3.5 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 60% of Medical Devices peers (233 compared).
Modeled value ranks above 66% of those peers.
Closest niche peers: Empowered Diagnostics, LLC, Advanced Surgical Center, LLC, Tribal Diagnostics Inc., Virgo Surgical Video Solutions, Inc., Burst Diagnostics, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.